Logo

American Heart Association

  2
  0


Final ID: Mo4145

Echocardiographic Risk Prediction of Outcomes in Acutely Ill Pulmonary Arterial Hypertension Patients

Abstract Body (Do not enter title and authors here): Background: Despite advancements in pulmonary arterial hypertension (PAH) management both in-hospital and long-term mortality remain high for those admitted to the ICU.

Aims: We sought to identify echocardiographic predictors of outcomes and to develop a straightforward risk prediction score to predict one-year mortality in ICU-admitted PAH patients.

Methods. This single-center, retrospective study examines adult PAH patients hospitalized in the JHH ICU from January 2010 to December 2020. Echocardiographic indices were collected and associated with outcomes using Cox proportional hazards (CPH) modeling to predict one-year mortality. Using these indices as well as clinical and lab data, a machine learning (ML) prediction model, Random Survival Forest (RSF), was trained and evaluated with a time-varying area under the curve (AUC).

Results. Out of 102 PAH patients, 77 had complete echocardiograms at index hospitalization. Baseline characteristics are presented in Table 1. Right ventricular (RV) dilatation, RV contractile dysfunction (impaired TAPSE, FAC, and RVFWLS), more positive RA conduit strain, and RV-pulmonary artery (PA) uncoupling were associated with increased one-year mortality after adjusting for age, sex, race, and functional class (Figure1A). Kaplan-Meier survival curves revealed that TAPSE, TAPSE/PASP, RVFWLS, and RVFWLS/PASP have significant prognostic discriminative ability at optimal thresholds of 13 mm, 15 mm/mmHg, -9.5%, and 15%/mmHg, respectively. Our best ML RSF model achieved a mean time-varying AUC of 0.73 (Figure1B), with the top five predictors being estimated 4-chamber LV end-diastolic volume, FAC, echo-derived PASP, RVFWLS, and echo-estimated pulmonary vascular resistance (Figure1C-D).

Conclusion. Echocardiographic right heart functional indices are associated with one-year mortality in ICU-admitted PAH patients. Employing these parameters in an ML model was predictive of adverse clinical outcomes.
  • Malhi, Jasmine  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Damico, Rachel  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Kolb, Todd  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Mathai, Stephen  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Hassoun, Paul  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Mukherjee, Monica  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Mombeini, Hoda  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Jani, Vivek  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Naranjo, Mario  ( Temple University , Philadelphia , Pennsylvania , United States )
  • Mercurio, Valentina  ( Federico II University , Naples , Italy )
  • Osgueritchian, Ryan  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Hassan, Hussein  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Hsu, Steven  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Simpson, Catherine  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Author Disclosures:
    Jasmine Malhi: No Answer | Rachel Damico: DO NOT have relevant financial relationships | Todd Kolb: DO NOT have relevant financial relationships | Stephen Mathai: DO have relevant financial relationships ; Consultant:Janssen:Past (completed) ; Consultant:Acceleron:Past (completed) ; Consultant:Merck:Active (exists now) ; Consultant:United Therapeutics:Past (completed) | Paul Hassoun: DO have relevant financial relationships ; Advisor:MSD:Active (exists now) | Monica Mukherjee: DO have relevant financial relationships ; Researcher:NHLBI:Active (exists now) ; Researcher:Department of Defense:Active (exists now) ; Researcher:National Scleroderma Foundation:Past (completed) ; Consultant:Advarra, Inc:Active (exists now) | Hoda Mombeini: DO NOT have relevant financial relationships | Vivek Jani: DO NOT have relevant financial relationships | Mario Naranjo: No Answer | Valentina Mercurio: No Answer | Ryan Osgueritchian: DO NOT have relevant financial relationships | Hussein Hassan: No Answer | Steven Hsu: DO NOT have relevant financial relationships | Catherine Simpson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

New Ways to Assess the Pulmonary Vasculature and Right Ventricle

Monday, 11/18/2024 , 01:30PM - 02:30PM

Abstract Poster Session

More abstracts on this topic:
Accelerometer-Measured Sedentary Behavior and Future Cardiovascular Disease

Ajufo Ezimamaka, Kany Shinwan, Ramo Joel, Churchill Timothy, Guseh James, Aragam Krishna, Ellinor Patrick, Khurshid Shaan

BMP10 as novel marker for right atrial dilatation and pressure in precapillary pulmonary hypertension

Llucia-valldeperas Aida, Van Wezenbeek Jessie, Groeneveldt Joanne, Sanchez-duffhues Gonzalo, Vonk Noordegraaf Anton, Bogaard Harm, Goumans Marie Jose, De Man Frances

More abstracts from these authors:
Pulmonary Artery Distensibility in Pulmonary Artery Hypertension: Comparison of Cardiac Magnetic Resonance with Echocardiography

Giacalone Marco, Hassoun Paul, Mukherjee Monica, Mombeini Hoda, Mercurio Valentina, Jani Vivek, Osgueritchian Ryan, Shah Ami, Zimmerman Stefan, Ambale Venkatesh Bharath, Mathai Stephen

Refining Risk Prediction in Systemic Sclerosis Pulmonary Arterial Hypertension

Osgueritchian Ryan, Shah Ami, Mathai Stephen, Mukherjee Monica, Mombeini Hoda, Jani Vivek, Gami Abhishek, Hsu Steven, Hummers Laura, Wigley Fredrick, Lammi Matthew, Hassoun Paul

You have to be authorized to contact abstract author. Please, Login
Not Available